EPA held a two-day public meeting of the Science Advisory Board (SAB) on June 5 and 6, 2019. Along with testimony, the SAB heard remarks from EPA Administrator Andrew Wheeler and discussed EPA’s proposed Science and Transparency Rule, planned actions on EPA’s 2018 Spring Regulatory Agenda, actions related to updating EPA guidelines for carcinogen and non-cancer assessment, a self-initiated SAB project to evaluate the “scientific” aspects of EPA’s co-benefit calculations, EPA’s proposed PFAS Plan, and proposed Waters of the U.S. rule.
On Wednesday, June 5, 2019, EPN members presented oral and written testimony during the public meeting of the SAB, critiquing EPA’s plan to revise its guidelines for carcinogen and non-cancer risk assessment, the Transparency Rule, and co-benefits.
EPN Summary of Testimony Written by Dr. Bernard Goldstein, former Chair, EPA Clean Air Scientific Advisory Committee, and former EPA Assistant Administrator for Research and Development
Complete Testimony Written by Dr. Bernard Goldstein
Summary of Testimony by EPN Member John Bachmann, former EPA Associate Director for Science/Policy and New Programs for the Office of Air Quality Planning and Standards
Complete Testimony of EPN member John Bachmann
Summary of Testimony by EPN Member Penny Fenner-Crisp, former Senior Science Advisor to the Director, EPA Office of Pesticide Programs
Complete Oral Testimony of EPN member Penny Fenner-Crisp
Complete Written Testimony of EPN member Penny Fenner-Crisp
In addition, here are Related Documents and Resources from the June 5, 2019, meeting, including EPN and EPN member comments; comments by Genna Reed, Lead Science and Policy Analyst, Union of Concerned Scientists Center for Science and Democracy; and comments by former SAB member Dr. H. Christopher Frey: Related Documents and Resources